Development of a genotyping microarray for Usher syndrome
Open Access
- 11 August 2006
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 44 (2), 153-160
- https://doi.org/10.1136/jmg.2006.044784
Abstract
Background: Usher syndrome, a combination of retinitis pigmentosa (RP) and sensorineural hearing loss with or without vestibular dysfunction, displays a high degree of clinical and genetic heterogeneity. Three clinical subtypes can be distinguished, based on the age of onset and severity of the hearing impairment, and the presence or absence of vestibular abnormalities. Thus far, eight genes have been implicated in the syndrome, together comprising 347 protein-coding exons. Methods: To improve DNA diagnostics for patients with Usher syndrome, we developed a genotyping microarray based on the arrayed primer extension (APEX) method. Allele-specific oligonucleotides corresponding to all 298 Usher syndrome-associated sequence variants known to date, 76 of which are novel, were arrayed. Results: Approximately half of these variants were validated using original patient DNAs, which yielded an accuracy of >98%. The efficiency of the Usher genotyping microarray was tested using DNAs from 370 unrelated European and American patients with Usher syndrome. Sequence variants were identified in 64/140 (46%) patients with Usher syndrome type I, 45/189 (24%) patients with Usher syndrome type II, 6/21 (29%) patients with Usher syndrome type III and 6/20 (30%) patients with atypical Usher syndrome. The chip also identified two novel sequence variants, c.400C>T (p.R134X) in PCDH15 and c.1606T>C (p.C536S) in USH2A. Conclusion: The Usher genotyping microarray is a versatile and affordable screening tool for Usher syndrome. Its efficiency will improve with the addition of novel sequence variants with minimal extra costs, making it a very useful first-pass screening tool.Keywords
This publication has 54 references indexed in Scilit:
- Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosaExperimental Eye Research, 2004
- Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 familiesHuman Mutation, 2000
- Arrayed Primer Extension: Solid-Phase Four-Color DNA Resequencing and Mutation Detection TechnologyGenetic Testing, 2000
- Mutations in the myosin VIIA gene cause non-syndromic recessive deafnessNature Genetics, 1997
- The prevalence of Usher syndrome and other retinal dystrophy‐hearing impairment associationsClinical Genetics, 1997
- Multiplex, fluorescent, solid-phase minisequencing for efficient screening of DNA sequence variationClinical Chemistry, 1996
- Mutation detection by solid phase primer extensionHuman Mutation, 1996
- Defective myosin VIIA gene responsible for Usher syndrome type IBNature, 1995
- Clinical diagnosis of the Usher syndromesAmerican Journal of Medical Genetics, 1994
- Genetic epidemiological studies of early‐onset deafness in the U.S. school‐age populationAmerican Journal of Medical Genetics, 1993